Wells Fargo & Company Eargo, Inc. Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.49 - $0.73 $1 - $2	4 Added 0.02%	20,324 $11,000
Q3 2022 Nov 14, 2022	BUY	$0.7 - $3.0 $13,870 - $59,445	19,815 Added 3923.76%	20,320 $21,000
Q2 2022 Aug 12, 2022	SELL	$0.75 - $5.6 $4,799 - $35,834	-6,399 Reduced 92.69%	505 $0
Q1 2022 May 16, 2022	SELL	$3.3 - $7.28 $35,310 - $77,896	-10,700 Reduced 60.78%	6,904 $37,000
Q4 2021 Feb 14, 2022	BUY	$4.6 - $10.21 $75,343 - $167,229	16,379 Added 1337.06%	17,604 $90,000
Q3 2021 Nov 15, 2021	SELL	$6.59 - $38.71 $68,568 - $402,777	-10,405 Reduced 89.47%	1,225 $8,000
Q2 2021 Aug 16, 2021	SELL	$32.1 - $57.78 $722,185 - $1.3 Million	-22,498 Reduced 65.92%	11,630 $464,000
Q1 2021 May 13, 2021	BUY	$42.5 - $75.37 $92,055 - $163,251	2,166 Added 6.78%	34,128 $1.71 Million
Q4 2020 Feb 09, 2021	BUY	$33.49 - $57.94 $1.07 Million - $1.85 Million	31,962 New	31,962 $1.43 Million

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.